Prediction of upgrade to clinically significant prostate cancer in patients under active surveillance: performance of a fully automated AI-algorithm for lesion detection and classification.

AI-augmented lesion detection and PI-RADS scoring is a robust tool to detect progression to clinically significant PCa in patients under AS. Integration in the clinical workflow can serve as reassurance for the reader and streamline reporting, hence improve efficiency and diagnostic confidence. This article is protected by copyright. All rights reserved.